CLDN1 and perineurioma: Immunohistochemical (IHC) analysis confirmed these dual components: schwannoma/perineurioma hybrids were positive for S100 and SOX10 in schwannomatous regions, while perineuriomatous areas expressed EMA, Claudin-1, and GLUT-1.